Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerotic Graft-versus-host Disease (GVHD)”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03954236
What this trial is testing

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease

Who this might be right for
Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Memorial Sloan Kettering Cancer Center 24
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Not applicableEnded earlyNCT02881047
What this trial is testing

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Who this might be right for
Subjects With Severe, Refractory Sclerotic Skin Changes
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Study completedNCT03616184
What this trial is testing

Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids

Who this might be right for
Graft-versus-host-disease (GVHD)
University of Nebraska 49
Testing effectiveness (Phase 2)Looking for participantsNCT07011810
What this trial is testing

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 50
Not applicableEnded earlyNCT04954573
What this trial is testing

Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease

Who this might be right for
Morphea (Circumscribed Scleroderma)Sclerotic Graft-versus-host Disease (GVHD)
Medical University of Graz 11
Testing effectiveness (Phase 2)Ended earlyNCT01898377
What this trial is testing

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Who this might be right for
Chronic Graft-versus-host Disease
Seoul National University Hospital 9
Not applicableStudy completedNCT05544448
What this trial is testing

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

Who this might be right for
Autoimmune DiseasesInflammatory DiseaseAcquired Bone Marrow Aplasia+8 more
Assistance Publique - Hôpitaux de Paris 67
Not applicableStudy completedNCT01206309
What this trial is testing

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host DiseaseCutaneous SclerosisBronchiolitis Obliterans
Fred Hutchinson Cancer Center 911
Not applicableStudy completedNCT04752397
What this trial is testing

The Influence of Extracorporeal Photopheresis on Skin Sclerosis

Who this might be right for
Scleroderma, SystemicGraft Vs Host DiseaseEosinophilic Fasciitis+2 more
Charite University, Berlin, Germany 6
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Testing effectiveness (Phase 2)Ended earlyNCT04111497
What this trial is testing

Glasdegib for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseFasciitis
Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT00702689
What this trial is testing

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Sclerotic Graft Versus Host DiseaseImatinib Mesylate
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)UnknownNCT03415867
What this trial is testing

Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease

Who this might be right for
Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 21
Testing effectiveness (Phase 2)Study completedNCT01309997
What this trial is testing

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseSystemic Scleroderma
Lee, Stephanie 72